nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. [electronic resource]
Producer: 20130115Description: 260-269 p. digitalISSN:- 2159-8290
- Albumins -- administration & dosage
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Pancreatic Ductal -- drug therapy
- Cytidine Deaminase -- metabolism
- Deoxycytidine -- administration & dosage
- Disease Models, Animal
- Drug Synergism
- Mice
- Paclitaxel -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.